Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacqueline Boultwood

Showing results (1-10 of 144) with videos related to

Pageof 15
Sort By:
Pediatric Reports|November 5, 2011
The role of haploinsufficiency of RPS14 and p53 activation in the molecular pathogenesis of the 5q- syndromeJacqueline Boultwood
Blood|February 9, 2013
CUX1 in leukemia: dosage mattersJacqueline Boultwood
Advances in Biological Regulation|October 5, 2025
Induced pluripotent stem cell-based modelling of disease evolution in myeloid leukemia: MDS to AMLJacqueline Boultwood
Advances in Biological Regulation|September 19, 2016
Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applicationsAndrea Pellagatti, Jacqueline Boultwood
Nature Medicine|July 8, 2014
Reduced translation of GATA1 in Diamond-Blackfan anemiaJacqueline Boultwood, Andrea Pellagatti
Mediterranean Journal of Hematology and Infectious Diseases|June 16, 2015
Recent Advances in the 5q- SyndromeAndrea Pellagatti, Jacqueline Boultwood
The Lancet. Haematology|December 22, 2015
Clinical associations of CSNK1A1 mutation in myelodysplastic syndromeJacqueline Boultwood, Andrea Pellagatti
Advances in Biological Regulation|December 28, 2020
SF3B1 mutant myelodysplastic syndrome: Recent advancesAndrea Pellagatti, Jacqueline Boultwood
Advances in Biological Regulation|October 10, 2022
Splicing factor mutations in the myelodysplastic syndromes: Role of key aberrantly spliced genes in disease pathophysiology and treatmentAndrea Pellagatti, Jacqueline Boultwood
Hemasphere|March 21, 2022
The impact of spliceosome mutations in MDSJacqueline Boultwood, Andrea Pellagatti
Pageof 15

Showing results (1-10 of 144) with videos related to

Sort By:
Pageof 15
Pediatric Reports|November 5, 2011
The role of haploinsufficiency of RPS14 and p53 activation in the molecular pathogenesis of the 5q- syndromeJacqueline Boultwood
Blood|February 9, 2013
CUX1 in leukemia: dosage mattersJacqueline Boultwood
Advances in Biological Regulation|October 5, 2025
Induced pluripotent stem cell-based modelling of disease evolution in myeloid leukemia: MDS to AMLJacqueline Boultwood
Advances in Biological Regulation|September 19, 2016
Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applicationsAndrea Pellagatti, Jacqueline Boultwood
Nature Medicine|July 8, 2014
Reduced translation of GATA1 in Diamond-Blackfan anemiaJacqueline Boultwood, Andrea Pellagatti
Mediterranean Journal of Hematology and Infectious Diseases|June 16, 2015
Recent Advances in the 5q- SyndromeAndrea Pellagatti, Jacqueline Boultwood
The Lancet. Haematology|December 22, 2015
Clinical associations of CSNK1A1 mutation in myelodysplastic syndromeJacqueline Boultwood, Andrea Pellagatti
Advances in Biological Regulation|December 28, 2020
SF3B1 mutant myelodysplastic syndrome: Recent advancesAndrea Pellagatti, Jacqueline Boultwood
Advances in Biological Regulation|October 10, 2022
Splicing factor mutations in the myelodysplastic syndromes: Role of key aberrantly spliced genes in disease pathophysiology and treatmentAndrea Pellagatti, Jacqueline Boultwood
Hemasphere|March 21, 2022
The impact of spliceosome mutations in MDSJacqueline Boultwood, Andrea Pellagatti
Pageof 15